Shun-Fa Yang Selected Research

Lung Neoplasms (Lung Cancer)

3/2024	Evaluation of the clinical significance of long non-coding RNA MALAT1 genetic variants in human lung adenocarcinoma.
12/2021	Effects of NAC and Gallic Acid on the Proliferation Inhibition and Induced Death of Lung Cancer Cells with Different Antioxidant Capacities.
12/2021	Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan.
1/2021	Novel function of PERP-428 variants impacts lung cancer risk through the differential regulation of PTEN/MDM2/p53-mediated antioxidant activity.
10/2020	Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients.
10/2020	Impact of Aurora Kinase A Polymorphism and Epithelial Growth Factor Receptor Mutations on the Clinicopathological Characteristics of Lung Adenocarcinoma.
9/2020	Association between EGFR Gene Mutation and Antioxidant Gene Polymorphism of Non-Small-Cell Lung Cancer.
4/2020	Association of Carbonic Anhydrase 9 Polymorphism and the Epithelial Growth Factor Receptor Mutations in Lung Adenocarcinoma Patients.
1/2019	Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist.
12/2017	Correlation between resistin gene polymorphism and clinical aspects of lung cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shun-Fa Yang Research Topics

Disease

270	Neoplasms (Cancer) 05/2024 - 01/2003
101	Neoplasm Metastasis (Metastasis) 04/2024 - 07/2004
85	Mouth Neoplasms (Oral Cancer) 01/2024 - 06/2003
56	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 09/2003
47	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2024 - 07/2007
46	Carcinogenesis 03/2024 - 10/2007
37	Squamous Cell Carcinoma of Head and Neck 01/2023 - 06/2003
34	Inflammation (Inflammations) 03/2022 - 06/2002
28	Osteosarcoma (Osteogenic Sarcoma) 12/2023 - 06/2004
23	Lymphatic Metastasis 03/2024 - 03/2008
23	Pneumonia (Pneumonitis) 01/2021 - 02/2005
22	Carcinoma (Carcinomatosis) 01/2023 - 04/2005
21	Adenocarcinoma of Lung 03/2024 - 05/2012
20	Lung Neoplasms (Lung Cancer) 03/2024 - 07/2004
20	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 09/2013
15	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2015 - 01/2008
14	Infections 01/2022 - 06/2006
13	Nasopharyngeal Carcinoma 03/2023 - 03/2010
11	Disease Progression 07/2022 - 03/2003
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 10/2011
10	Diabetes Mellitus 01/2023 - 04/2008
10	Hypoxia (Hypoxemia) 08/2022 - 05/2012
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2020 - 10/2013
9	Fibrosis (Cirrhosis) 12/2022 - 03/2009
9	Hypertension (High Blood Pressure) 06/2022 - 03/2013
9	Osteoarthritis 01/2022 - 01/2004
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2005
8	Anorexia 07/2011 - 04/2005
7	Type 2 Diabetes Mellitus (MODY) 01/2024 - 05/2021
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2022 - 10/2007
7	Leukemia 12/2019 - 06/2005
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2018
6	Liver Neoplasms (Liver Cancer) 01/2023 - 06/2013
6	Breast Neoplasms (Breast Cancer) 10/2021 - 09/2006
6	Cardiovascular Diseases (Cardiovascular Disease) 08/2021 - 10/2009
6	Atherosclerosis 01/2019 - 07/2002
6	Oral Submucous Fibrosis 09/2014 - 02/2002
5	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2024 - 01/2022
5	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024 - 02/2013

Drug/Important Bio-Agent (IBA)

55	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2002
41	Matrix Metalloproteinases (MMPs)IBA 08/2023 - 06/2002
37	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2021 - 02/2002
36	Messenger RNA (mRNA)IBA 03/2024 - 09/2003
32	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2009
30	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2023 - 07/2004
28	MelatoninIBA 08/2023 - 03/2015
24	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2023 - 07/2002
22	Plasminogen Activators (Plasminogen Activator)IBA 12/2023 - 07/2004
21	Long Noncoding RNAIBA 05/2024 - 01/2019
19	Environmental CarcinogensIBA 01/2020 - 03/2011
16	FlavonoidsIBA 04/2024 - 01/2007
16	CytokinesIBA 12/2023 - 06/2002
15	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 02/2005
14	CaspasesIBA 05/2024 - 12/2013
14	Peptide Hydrolases (Proteases)FDA Link 09/2020 - 03/2008
13	p38 Mitogen-Activated Protein KinasesIBA 05/2024 - 10/2007
13	CurcuminIBA 01/2024 - 03/2020
12	Carbonic Anhydrase IXIBA 01/2022 - 01/2012
12	GelatinIBA 10/2019 - 06/2003
12	GelatinasesIBA 10/2009 - 06/2003
11	ErbB Receptors (EGF Receptor)IBA 12/2022 - 01/2016
11	AntioxidantsIBA 12/2021 - 10/2013
10	Small Interfering RNA (siRNA)IBA 01/2023 - 11/2011
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 10/2004
10	Lipocalin-2IBA 11/2022 - 05/2011
9	Tissue Inhibitor of Metalloproteinase-3IBA 01/2023 - 09/2014
9	A-factor (Streptomyces)IBA 05/2017 - 10/2009
8	EnzymesIBA 04/2024 - 03/2003
8	Tissue Inhibitor of Metalloproteinase-2IBA 11/2022 - 07/2002
8	Cadherins (E-Cadherin)IBA 04/2022 - 09/2011
8	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022 - 05/2007
8	Mitogen-Activated Protein KinasesIBA 07/2019 - 04/2007
7	Caspase 3 (Caspase-3)IBA 01/2024 - 02/2012
7	JNK Mitogen-Activated Protein KinasesIBA 01/2024 - 04/2007
7	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 05/2016
7	MicroRNAs (MicroRNA)IBA 08/2022 - 01/2012
7	HMGB1 Protein (HMG1)IBA 10/2020 - 04/2015
7	pterostilbeneIBA 01/2019 - 01/2014
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2016 - 09/2010
7	Plasminogen Activator Inhibitor 1IBA 01/2015 - 06/2003
7	Fibrinolysin FDA Link 01/2011 - 05/2003
6	tricetinIBA 04/2024 - 01/2015
6	WW Domain-Containing OxidoreductaseIBA 01/2023 - 10/2016
6	Type 4 Fibroblast Growth Factor ReceptorIBA 05/2021 - 01/2015
6	PTX3 proteinIBA 01/2021 - 10/2011
6	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2019 - 06/2010
6	Urokinase Plasminogen Activator ReceptorsIBA 01/2019 - 02/2006
6	Carbonic Anhydrases (Carbonic Anhydrase)IBA 09/2017 - 09/2003
6	Glutathione Transferase (Glutathione S-Transferase)IBA 11/2011 - 04/2005
5	Tumor Biomarkers (Tumor Markers)IBA 04/2024 - 01/2014
5	Insulin-Like PeptidesIBA 01/2024 - 07/2010
5	RNA (Ribonucleic Acid)IBA 01/2024 - 09/2019
5	norcantharidinIBA 12/2022 - 01/2012
5	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022 - 10/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2014
5	CarcinogensIBA 01/2022 - 12/2012

Therapy/Procedure

40	Therapeutics 05/2024 - 06/2004
19	Drug Therapy (Chemotherapy) 08/2023 - 01/2014
7	Radiotherapy 08/2023 - 01/2015
5	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 04/2014